Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrate improvement in disease activity.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/systemic-treatment-sj%C3%B6gren-disease-closer-successful-2025a1000u37?src=rss
Author :
Publish date : 2025-11-03 13:24:00
Copyright for syndicated content belongs to the linked Source.